Alisa Lask

Insider Reports History

Entity
Individual
Location
C/O 380 Lackawanna Place, South Orange, NJ
Signature
/s/ Christopher Melsha as attorney-in-fact for Alisa Lask pursuant to power of attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alisa Lask:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEPHROS INC Director Common Stock 48.6K $119K $2.45 May 14, 2024 Direct
RVL Pharmaceuticals plc Director Ordinary Shares 113K $3.51K $0.03 Aug 10, 2023 Direct
NEPHROS INC Director Stock Option (right to buy) 7.32K May 14, 2024 Direct

Insider Reports Filed by Alisa Lask

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEPH NEPHROS INC May 14, 2024 1 $0 4 May 16, 2024 Director
NEPH NEPHROS INC Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
RVLP RVL Pharmaceuticals plc Aug 10, 2023 1 -$5.88K 4 Aug 14, 2023 Director
RVLP RVL Pharmaceuticals plc Jul 5, 2023 1 $0 4 Jul 11, 2023 Director
NEPH NEPHROS INC Jan 5, 2023 2 $0 4 Jan 9, 2023 Director
RVLP RVL Pharmaceuticals plc Aug 10, 2022 1 $0 4 Aug 12, 2022 Director
RVLP RVL Pharmaceuticals plc Aug 10, 2022 0 $0 3 Aug 12, 2022 Director
NEPH NEPHROS INC Dec 14, 2021 2 $0 4 Dec 16, 2021 Director